Castlight Health, inc. (CSLT) CEO John C. Doyle Sells 3,289 Shares
Castlight Health, inc. (NYSE:CSLT) CEO John C. Doyle sold 3,289 shares of the stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $3.90, for a total value of $12,827.10. Following the completion of the sale, the chief executive officer now owns 71,115 shares of the company’s stock, valued at $277,348.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Castlight Health, inc. (CSLT) traded down 6.41% on Thursday, hitting $3.65. The stock had a trading volume of 1,076,299 shares. Castlight Health, inc. has a 12-month low of $3.05 and a 12-month high of $5.50. The stock has a 50 day moving average price of $4.23 and a 200-day moving average price of $3.80. The company’s market cap is $480.66 million.
Castlight Health, inc. (NYSE:CSLT) last posted its earnings results on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.02. Castlight Health, inc. had a negative return on equity of 36.30% and a negative net margin of 42.54%. The business had revenue of $32.10 million during the quarter, compared to the consensus estimate of $31.14 million. During the same period in the previous year, the business earned ($0.11) EPS. The business’s quarterly revenue was up 36.0% on a year-over-year basis. On average, equities analysts expect that Castlight Health, inc. will post ($0.25) earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/08/17/castlight-health-inc-cslt-ceo-john-c-doyle-sells-3289-shares.html.
Hedge funds have recently bought and sold shares of the stock. State Street Corp increased its stake in Castlight Health, inc. by 11.3% in the fourth quarter. State Street Corp now owns 663,065 shares of the software maker’s stock valued at $3,277,000 after buying an additional 67,459 shares during the last quarter. Teachers Advisors LLC increased its stake in Castlight Health, inc. by 8.1% in the fourth quarter. Teachers Advisors LLC now owns 62,781 shares of the software maker’s stock valued at $311,000 after buying an additional 4,717 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in Castlight Health, inc. during the first quarter valued at $329,000. Cowen Prime Services LLC purchased a new stake in Castlight Health, inc. during the first quarter valued at $183,000. Finally, Oxford Asset Management purchased a new stake in Castlight Health, inc. during the first quarter valued at $102,000. 40.17% of the stock is owned by institutional investors and hedge funds.
A number of equities research analysts have commented on the company. ValuEngine cut Castlight Health, inc. from a “hold” rating to a “sell” rating in a research note on Friday, May 19th. Zacks Investment Research upgraded Castlight Health, inc. from a “sell” rating to a “hold” rating in a research note on Tuesday, June 27th. BidaskClub upgraded Castlight Health, inc. from a “hold” rating to a “buy” rating in a research note on Wednesday, July 12th. Chardan Capital assumed coverage on Castlight Health, inc. in a research note on Tuesday, June 6th. They issued a “buy” rating and a $4.50 price target for the company. Finally, Dougherty & Co assumed coverage on Castlight Health, inc. in a research note on Wednesday, May 10th. They issued a “buy” rating and a $5.50 price target for the company. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $4.57.
About Castlight Health, inc.
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.